UNITUXIN 17.5MG/5ML
UNITUXIN
17.5MG/5ML (3.5MG/ML)
| Principio Activo | DINUTUXIMAB |
|---|---|
| Estatus | A |
| Indicación Terapéutica | TREATMENT FOR CHILDREN WITH HIGH-RISK NEUROBLASTOMA |
| Aprobado por | EMA, FDA |
| Cold chain | No |
17.5MG/5ML (3.5MG/ML)
UNITUXIN 17.5MG/5ML
| Principio Activo | DINUTUXIMAB |
|---|---|
| Estatus | A |
| Indicación Terapéutica | TREATMENT FOR CHILDREN WITH HIGH-RISK NEUROBLASTOMA |
| Aprobado por | EMA, FDA |
| Cold chain | No |
Valoraciones
No hay valoraciones aún.